17α Hydroxylase/17,20 lyase deficiency: clinical features and genetic insights from a large Turkey cohort
Zeynep Siklar,Emine Camtosun,Semih Bolu,Melek Yildiz,Aysehan Akinci,Firdevs Bas,İsmail Dündar,Asli Bestas,Edip Ünal,Pinar Kocaay,Tulay Guran,Gonul Buyukyilmaz,Aylin Kilinc Ugurlu,Buşra Gurpinar Tosun,Ihsan Turan,Erdal Kurnaz,Bilgin Yuksel,Doga Turkkahraman,Atilla Cayir,Gamze Celmeli,E. Nazli Gonc,Beray Selver Eklioğlu,Semra Cetinkaya,Seniha Kiremitci Yilmaz,Mehmet Emre Atabek,Muammer Buyukinan,Emrullah Arslan,Eda Mengen,Esra Deniz Papatya Cakir,Murat Karaoglan,Nihal Hatipoglu,Zerrin Orbak,Ahmet Ucar,Nesibe Akyurek,Emine Demet Akbas,Emregül Isik,Sare Betul Kaygusuz,Zumrut Kocabey Sutcu,Gulcan Seymen,Merih Berberoglu
DOI: https://doi.org/10.1007/s12020-024-03962-6
2024-07-19
Endocrine
Abstract:17α Hydroxylase/17,20 lyase deficiency (17OHD) is a rare form of congenital adrenal hyperplasia, typically diagnosed in late adolescence with symptoms of pubertal delay and hypertension. This study aimed to determine the clinical and laboratory characteristics of 17OHD cases and gather data on disease management.
endocrinology & metabolism